| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6022409 | Neurobiology of Disease | 2013 | 8 Pages |
Abstract
⺠Antibodies to HIV Tat protein attenuate Tat-mediated neurotoxicity. ⺠Tat immune complexes also block neurotoxicity caused by NMDA receptor agonists. ⺠Vaccine therapies targeting Tat may prevent HIV-associated cognitive impairment.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jeffrey A. Rumbaugh, Muznabanu Bachani, Wenxue Li, Tracy R. Butler, Katherine J. Smith, Mario A. Bianchet, Tongguang Wang, Mark A. Prendergast, Ned Sacktor, Avindra Nath,